KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Progyny (PGNY) EBT (2018 - 2025)

Progyny (PGNY) has disclosed EBT for 8 consecutive years, with $33.6 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT changed N/A to $33.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $108.8 million, a N/A change, with the full-year FY2025 number at $85.3 million, up 2.49% from a year prior.
  • EBT was $33.6 million for Q4 2025 at Progyny, up from $21.5 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $33.6 million in Q4 2025 to a low of -$398000.0 in Q4 2021.
  • A 5-year average of $15.9 million and a median of $16.3 million in 2023 define the central range for EBT.
  • Peak YoY movement for EBT: crashed 133.84% in 2021, then skyrocketed 11600.7% in 2023.
  • Progyny's EBT stood at -$398000.0 in 2021, then soared by 1140.45% to $4.1 million in 2022, then surged by 292.71% to $16.3 million in 2023, then increased by 10.45% to $18.0 million in 2024, then surged by 87.11% to $33.6 million in 2025.
  • Per Business Quant, the three most recent readings for PGNY's EBT are $33.6 million (Q4 2025), $21.5 million (Q3 2025), and $27.1 million (Q2 2025).